Torem 2.5mg tablets

País: Reino Unido

Língua: inglês

Origem: MHRA (Medicines & Healthcare Products Regulatory Agency)

Ingredientes ativos:

Torasemide

Disponível em:

Viatris UK Healthcare Ltd

Código ATC:

C03CA04

DCI (Denominação Comum Internacional):

Torasemide

Dosagem:

2.5mg

Forma farmacêutica:

Oral tablet

Via de administração:

Oral

Classe:

No Controlled Drug Status

Tipo de prescrição:

Valid as a prescribable product

Resumo do produto:

BNF: 02020200; GTIN: 5000471005349

Folheto informativo - Bula

3OHDVHUHDGDOORIWKLVOHDÀHW
CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE.
‡
.HHSWKLVOHDIOHW

Leia o documento completo

Características técnicas

OBJECT 1
TOREM 2.5 MG TABLETS
Summary of Product Characteristics Updated 29-May-2018 | Mylan
•
1. Name of the medicinal product
•
2. Qualitative and quantitative composition
•
3. Pharmaceutical form
•
4. Clinical particulars
•
4.1 Therapeutic indications
•
4.2 Posology and method of administration
•
4.3 Contraindications
•
4.4 Special warnings and precautions for use
•
4.5 Interaction with other medicinal products and other forms of
interaction
•
4.6 Fertility,pregnancy and lactation
•
4.7 Effects on ability to drive and use machines
•
4.8 Undesirable effects
•
4.9 Overdose
•
5. Pharmacological properties
•
5.1 Pharmacodynamic properties
•
5.2 Pharmacokinetic properties
•
5.3 Preclinical safety data
•
6. Pharmaceutical particulars
•
6.1 List of excipients
•
6.2 Incompatibilities
•
6.3 Shelf life
•
6.4 Special precautions for storage
•
6.5 Nature and contents of container
•
6.6 Special precautions for disposal and other handling
•
7. Marketing authorisation holder
•
8. Marketing authorisation number(s)
•
9. Date of first authorisation/renewal of the authorisation
•
10. Date of revision of the text
1. Name of the medicinal product
Torem 2.5mg Tablets
2. Qualitative and quantitative composition
Each tablet contains 2.5mg torasemide.
For the full list of excipients, see section 6.1
3. Pharmaceutical form
Tablets.
White to off-white round tablets with the imprint “T 2.5” on one
side and plain on the other side.
4. Clinical particulars
4.1 Therapeutic indications
Essential hypertension.
4.2 Posology and method of administration
_ADULTS_
_Essential hypertension:_ A dose of 2.5mg torasemide once daily is
recommended. If necessary, the dose
may be increased to 5mg once daily. Studies suggest that doses above
5mg daily will not lead to further
reduction in blood pressure. The maximum effect is exhibited after
approximately twelve weeks of
continuous treatment.
_ELDERLY_
No special dosage adjustments are necessary.
_CHILDREN_
There is no experience of torasemide in